Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELUXADOLINE vs EMICIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELUXADOLINE vs EMICIZUMAB: Safety Overview

Metric ELUXADOLINE EMICIZUMAB
Total FAERS Reports 2,353 733
Deaths Reported 37 42
Death Rate 1.6% 5.7%
Hospitalizations 413 159
Average Patient Age 57.4 yrs 30.7 yrs
% Female Patients 77.7% 7.1%
FDA Approval Date Mar 14, 2025 N/A
Manufacturer Allergan, Inc. Genentech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription